Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents.
Maristany S, DuVall AS, Stock W, Adeleye AJ. Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents. J Assist Reprod Genet. 2022 Aug; 39(8):1733-1738.
PMID: 35727422
Minding the gender gap in fertility: The rationale, obstacles, and strategies to improve utilization of fertility preservation.
Adeleye AJ, Feinberg E. Minding the gender gap in fertility: The rationale, obstacles, and strategies to improve utilization of fertility preservation. Med (N Y). 2022 05 13; 3(5):293-297.
PMID: 35584650
Considering race in the administration of fertility preservation. A commentary on: "Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in a major American city".
Adeleye AJ. Considering race in the administration of fertility preservation. A commentary on: "Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in a major American city". J Assist Reprod Genet. 2020 Dec; 37(12):3015-3016.
PMID: 33205357
Differences in perceived stress during ovarian stimulation between women with infertility and those pursing oocyte cryopreservation.
Adeleye A, Cruz K, Pasch L, Huddleston H. Differences in perceived stress during ovarian stimulation between women with infertility and those pursing oocyte cryopreservation. Fertil Steril. 2020 11; 114(5):1076-1084.
PMID: 32826049
Care of Transgender Persons.
Adeleye A, Lengyel E. Care of Transgender Persons. N Engl J Med. 2020 04 09; 382(15):1481-1482.
PMID: 32268038
Ovarian stimulation for fertility preservation or family building in a cohort of transgender men.
Adeleye AJ, Cedars MI, Smith J, Mok-Lin E. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men. J Assist Reprod Genet. 2019 Oct; 36(10):2155-2161.
PMID: 31435820
Transitioning from Infertility-Based (ART 1.0) to Elective (ART 2.0) Use of Assisted Reproductive Technologies and the DOHaD Hypothesis: Do We Need to Change Consenting?
Rinaudo P, Adeleye A. Transitioning from Infertility-Based (ART 1.0) to Elective (ART 2.0) Use of Assisted Reproductive Technologies and the DOHaD Hypothesis: Do We Need to Change Consenting? Semin Reprod Med. 2018 05; 36(3-04):204-210.
PMID: 30866007
Semen Parameters Among Transgender Women With a History of Hormonal Treatment.
Adeleye AJ, Reid G, Kao CN, Mok-Lin E, Smith JF. Semen Parameters Among Transgender Women With a History of Hormonal Treatment. Urology. 2019 02; 124:136-141.
PMID: 30312673
Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes.
Adeleye AJ, Aghajanova L, Kao CN, Cedars MI, Sauer MV. Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes. Fertil Steril. 2018 07 01; 110(1):83-88.
PMID: 29885884